Zenas BioPharma (ZBIO) Non-cash Items (2023 - 2026)

Zenas BioPharma's Non-cash Items history runs 4 years deep, the most recent figure standing at $68.9 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 4702.53% year-over-year to $68.9 million; the TTM figure through Mar 2026 stood at $68.9 million (up 4702.53% YoY), while the FY2025 annual figure was $3.2 million, up 148.11% from the prior year.
• Non-cash Items was $68.9 million for Q1 2026 at Zenas BioPharma, down from $244.0 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $244.0 million in Q4 2025 to a low of $1.0 million in Q3 2024.
• Historically, Non-cash Items has averaged $53.4 million across 4 years, with a median of $5.8 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Non-cash Items sank 73.97% in 2024, then surged 11495.96% in 2025.
• A 4-year view of Non-cash Items shows it stood at $8.1 million in 2023, then tumbled by 73.97% to $2.1 million in 2024, then soared by 11495.96% to $244.0 million in 2025, then sank by 71.76% to $68.9 million in 2026.
• The last three Non-cash Items figures came in at $68.9 million (Q1 2026), $244.0 million (Q4 2025), and $98.1 million (Q3 2025), per Business Quant data.